Period of time： 2013年4期
Publisher： Future Medicine
Founded in： 2005
Total resources： 67
ISSN： 1479-6694
Subject： R73 Oncology
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Future Oncology,volume 2,issue 4
Menu
3D assay reveals tumor cell movement
Future Oncology,volume 2,issue 4 , Vol. 2, Iss. 4, 2006-08 , pp.
Access to resources
Recommend
Nelarabine: efficacy in the treatment of clinical malignancies
By Roecker Andrew M,Allison Jeffery C,Kisor David F in (2006)
Future Oncology,volume 2,issue 4 , Vol. 2, Iss. 4, 2006-08 , pp.Cetuximab in squamous cell carcinoma of the head and neck
By Hitt Ricardo,Martín Patricia,Hidalgo Manuel in (2006)
Future Oncology,volume 2,issue 4 , Vol. 2, Iss. 4, 2006-08 , pp.Standardizing chronic graft-versus-host disease
Future Oncology,volume 2,issue 4 , Vol. 2, Iss. 4, 2006-08 , pp.Anatomically independent tumors revisited
By Kiaris Hippokratis in (2006)
Future Oncology,volume 2,issue 4 , Vol. 2, Iss. 4, 2006-08 , pp.Confocal laser endoscopy: new approach to the early diagnosis of tumors of the esophagus and stomach
By Goetz Martin,Hoffman Arthur,Galle Peter R,Neurath Markus F,Kiesslich Ralf in (2006)
Future Oncology,volume 2,issue 4 , Vol. 2, Iss. 4, 2006-08 , pp.Image-guided radiation therapy: current and future directions
By Allison Ron R,Gay Hiram A,Mota Helvecio C,Sibata Claudio H in (2006)
Future Oncology,volume 2,issue 4 , Vol. 2, Iss. 4, 2006-08 , pp.TRAIL receptor-targeted therapy
By Buchsbaum Donald J,Zhou Tong,LoBuglio Albert F in (2006)
Future Oncology,volume 2,issue 4 , Vol. 2, Iss. 4, 2006-08 , pp.Chemotherapy for advanced cholangiocarcinoma: what is standard treatment?
By Mazhar Danish,Stebbing Justin,Bower Mark in (2006)
Future Oncology,volume 2,issue 4 , Vol. 2, Iss. 4, 2006-08 , pp.Practical management of classical myeloproliferative disorder patients: a clinician’s guide
Future Oncology,volume 2,issue 4 , Vol. 2, Iss. 4, 2006-08 , pp.
Previous
Next